|
Meeting Planned on Notification Guidelines for Cardiac Devices
A plan to have CDRH’s Office of Device Evaluation (ODE) review 30-day notices of manufacturing changes, rather than the Office of Compliance, will first be piloted in the cardiovascular devices division, D&DL has learned.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives